Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Festo Ruling May Have Broad Implications In Hatch/Waxman Reform Debate

This article was originally published in The Tan Sheet

Executive Summary

The Supreme Court's decision in the Festo case paves the way for continued debate on Hatch/Waxman patent reform, but could be a blow to generic drug firms

You may also be interested in...

Hatch/Waxman Reform Should Await Pending Supreme Court Decision – Hatch

Congress should wait for an upcoming Supreme Court ruling on the Doctrine of Equivalents before beginning serious work on re-drafting the Hatch/Waxman Act, Sen. Orrin Hatch (R-Utah) said

People In Brief

Perrigo promotes in pricing, planning

In Brief

Combe sells most of its OTC brands





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts